(P-382) Characteristics and Outcomes of People with HIV (PWH) with Suboptimal Adherence on B/F/TAF or Dolutegravir Single-Tablet Regimens (STRs)

Trio Health
Louisville, Colorado, United States

Director, HIV Global Medical Affairs
Gilead Sciences
Forest City, California, United States

Executive Director, Global Medical Affairs
Gilead Sciences
Forest City, CA, United States

Senior Director, Analytics
Trio Health
Louisville, Colorado, United States

Gilead Sciences, Inc.
Foster City, California, United States

Gilead Sciences
Foster City, California, United States

Director, Epidemiology
Gilead Sciences, Inc.
Washington, DC, United States

Associate VP, Medical Affairs and Education
Monogram Biosciences/LabCorp
Laguna Beach, CA, United States

Professor
University of North Carolina at Chapel Hill School of Medicine
Chapel Hill, North Carolina, United States

Clinical Director, Division of Infectious Diseases; Professor of Medicine
Brigham and Women’s Hospital; Harvard Medical School
Boston, MA, United States

Chief Medical Officer
CareResource
Miami, Florida, United States

Medical Director
Midway Immunology and Research Center
Fort Pierce, Florida, United States